Artificial Intelligence
AI Could Quickly Screen Thousands of Antibiotics to Tackle Superbugs
As the threat of antibiotic resistance increases, new antibiotics are imperative—and AI could widen the pipeline
Pharmaceuticals1129 articles archived since 1845
Pharmaceuticals
Beyond Ozempic: New Obesity Drugs Could Be Cheaper and Even More Effective
Hormone mimics offer advantages even beyond those of the potent weight-loss shots on the market now
Pharmaceuticals
We Need to Better Regulate Nutraceuticals
Manufacturers of a class of food-derived supplements called nutraceuticals often make statements about their health value that are hard to verify, which can cause safety and efficacy issues...
Medicine
A Common Diabetes Drug May Prevent Long COVID in Some People
The drug metformin cut long COVID risk by 41 percent in both people who were overweight and those with obesity. But treatments remain elusive
Pharmaceuticals
Why There’s a Severe Shortage of Cancer Drugs
Many generic drugs for cancer and ADHD, blood thinners and antibiotics are in short supply, in part because there is little profit in making them
Pharmaceuticals
What Is Paxlovid Rebound, and How Common Is It?
President Biden is part of a minority of people who have experienced Paxlovid rebound, but experts say the drug should still be prescribed for those who need it
Sleep
Should You Give Your Kid Melatonin?
Young children are taking melatonin gummy supplements, but experts say they should be a last resort to help with sleep
Public Health
Deadly Bacteria in Eyedrops May Spread from Person to Person
Infections of a new strain of Pseudomonas aeruginosa that have led to blindness and death highlight the worsening antibiotic resistance crisis
Health Care
A Bad Medication Abortion Decision Threatens the Future Availability of Drugs in the U.S.
With an April 7 court decision, one judge has harmed women’s health and undermined trust in science-based drug approvals in the U.S.
Pharmaceuticals
Eye Drops Recalled after Deaths and Blindness—Here’s What to Know
Here’s how to tell whether your eye drops are safe to use and how to recognize a potential infection
Pharmaceuticals
U.S. Lawsuit Threatens Access to Abortion Drug: The Science behind the Case
A judge’s decision could ban mifepristone across the country and weaken the Food and Drug Administration’s authority
Epidemiology
COVID Rebound Can Happen Even without Paxlovid
Concerns about Paxlovid rebound are preventing some doctors from prescribing the lifesaving drug and some high-risk patients from taking it
Pharmaceuticals
How Antidepressants Help Bacteria Resist Antibiotics
A laboratory study unravels ways antidepressants and other nonantibiotic drugs can contribute to drug resistance
Pharmaceuticals
‘Breakthrough’ Obesity Drugs Are Effective but Raise Questions
Drugs that reduce excess weight linked to chronic health problems have shown striking results in trials and in practice
Pharmaceuticals
A Valuable COVID Drug Doesn’t Work against New Variants
Current monoclonal antibodies fail against COVID virus variants, so drugmakers want to use a fast-track test for new ones
Pharmaceuticals
$3.5-Million Hemophilia Gene Therapy Is World’s Most Expensive Drug
A hemophilia drug has the potential to save lives. But it cannot treat the most common form of the disease
Pharmaceuticals
Heralded Alzheimer’s Drug Works, but Safety Concerns Loom
Eisai and Biogen share clinical trial data confirming that lecanemab slows mental decline amid reports of potentially related deaths
Reproduction
Over-the-Counter Birth Control Pills Could Be Approved Next Year
If the U.S. Food and Drug Administration approves the first over-the-counter birth control pill, pharmacists and pharmacies could play an ever increasing role in reproductive health care...
Reproduction
Male Birth Control Is in Development, but Barriers Still Stand in the Way
A scientist who has been developing male birth control since the 1970s says safe, reversible and affordable options are possible
Pharmaceuticals
New Execution Method Touted as More ‘Humane,’ but Evidence Is Lacking
A legal battle over nitrogen hypoxia, a new potential method of execution, raises ethical questions
